期刊文献+

STAT_对肿瘤细胞分化增殖及抗凋亡的调节 被引量:2

下载PDF
导出
出处 《泸州医学院学报》 2003年第3期270-271,共2页 Journal of Luzhou Medical College
  • 引文网络
  • 相关文献

参考文献19

  • 1Garcia R , Bowman TL, Niu G, et al. Constitutive activation of STAT3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast Carcinoma cells [ J ]. Oncogene,2001; 20(20) : 2499. 被引量:1
  • 2Leaman DW , Leungs, Li X, et al. Regulation of stat - dependent pathway by growth factors and cytokines [J]. Faseb,1996; 10:1578. 被引量:1
  • 3Schindler C, Darneu JE Taga T, et al. Transcription response to polypeptider heads the JAK- STAT [ J ]. Aun Rev Biochem, 1995; 64:621. 被引量:1
  • 4Stev A, Benjamin B. Rituximab inactivates STAT3 activity in B - Non- Hodgkin' s Lymphoma through inhibition of the interleukin l0 autocrine/paractine loop and results in down- regulation of Bcl - 2 and senstivation to cytotoxic drugs [ J ]. Cancer Re, 2001 Julyl ; 61 : 5137. 被引量:1
  • 5Jose Z, Helen YW, Seeds G, et al. Regulation of cell growth by 11 - 2 : Role of STAT3 in Protection from Apoptosis but not in cell cycle progression [J]. J immunol, 1998; 160:3502. 被引量:1
  • 6Darnell JJ. STAT3 and gene regulation [J]. Science, 1997;277:1630. 被引量:1
  • 7Saharinen P , Ekman N, Sarvas K, et al. The Bmx tyrosine kinase induces activation of the STAT signaling pathway which is specifically inhibited by protein kinase c delta [ J ]. Blood,1997; 90:4341. 被引量:1
  • 8Dieter K, Vdo H, Martina V, et al. STAT3 is constitutively activated in Hodgkin cell lines [J]. Blood, 2001 ; 98:762. 被引量:1
  • 9Bromberg J, Wrzeszczynska M, Devgan G, et al. STAT3 as an oncogene [J]. Cell, 1999; 98:83. 被引量:1
  • 10Berclaz G, Altermatt HJ, Rohrobach V, et al. EGFR dependent expression of STAT3 (but not STAT1 ) in breast cancer[J]. Int J oncol, 2001; 19(6): 1155. 被引量:1

同被引文献43

  • 1王鸿程,陈洁,张程,曹乃清,许学亮,孙绍娟.非小细胞肺癌中Bax和CyclinD_1的表达及意义[J].泸州医学院学报,2005,28(1):1-3. 被引量:2
  • 2王鸿程,李艳萍,许学亮.肺腺癌细胞的STAT3信号传导途径的研究[J].泸州医学院学报,2006,29(2):95-97. 被引量:1
  • 3王鸿程,许学亮,曹乃清,孔智斌,陈洁,简丽萍.STAT3、Bcl-xL、Bax和CyclinD1在非小细胞肺癌中的表达[J].细胞与分子免疫学杂志,2007,23(4):341-342. 被引量:18
  • 4邵志敏 张杰 李方明 见:沈镇宙 邵志敏.乳腺癌的预后因素[A].见:沈镇宙,邵志敏.现代乳腺肿瘤学进展[C].上海:上海科学技术文献出版社,2002.4,79--]00. 被引量:2
  • 5傅西林.乳腺肿瘤病理组织学诊断[A].见:李树玲主编.乳腺肿瘤学[C].北京:科学技术文献出版社,2000.57~130. 被引量:2
  • 6Huang M.page C,Reynolds Rk, et al. Constitutive activation of stat3 oncongene product in human ovarian carcinoma cells [[]. Gynecol Oncol,2000;79(1):67 被引量:1
  • 7Alas S,Bonavida B.Kituximab Inactivates sig nalransdueer and activation of transcrption3 (Stat3)activity in B- non- Hodgkin'S lymphoma through inhibition of the Interleukin 10 autocrine/paracrine loop and results in down regulation of Bcl-2 and sensitization to cytotoxiedrugs [J].cancer Res,2001 ;61(13) :5137. 被引量:1
  • 8Puthier D,Thabard W ,Rapp M ,et al.lnterferonal alpha extends the survival of human myeloma cells through an upregulation of the Mcl-lanfiapop totiemolecule [J].BrJHaematol, 2001;112(3) : 358 被引量:1
  • 9Lin J .Jin x Rothman K,et al .Modulation of signal transducer and activator of transciption 3 activities by p53 tumor suppressor in breast cancer cells [J].cancer R.es,2002;62(2): 376 被引量:1
  • 10Bownan T.Gatcia R,Turkson J, et al. STATs in oncogeoe [J]. Oncogene, 2000,19(21):2474 被引量:1

引证文献2

;
使用帮助 返回顶部